Preparation of anastrozole loaded PEG-PLA nanoparticles: evaluation of apoptotic response of breast cancer cell lines

References

• HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
   PubMed Web of Science ®Google Scholar
• PłonkaJLatochaMKuśmierzDZielińskaAExpression of proapop-totic BAX and TP53 genes and antiapoptotic BCL-2 gene in MCF-7 and T-47D tumour cell cultures of the mammary gland after a photodynamic therapy with photolonAdv Clin Exp Med2015241374625923085
   PubMed Web of Science ®Google Scholar
• EdsonLHunterDColemanWAlteration of pro-apoptotic and anti-apoptotic gene expression in breast cancer cell lines (1047.7)FASEB J2014281 Supplement
   Google Scholar
• MilaniMJhaGPotterDAAnastrozole use in early stage breast cancer of post-menopausal womenClin Med Ther2009114115619794821
   PubMedGoogle Scholar
• MillerWRLarionovAAUnderstanding the mechanisms of aromatase inhibitor resistanceBreast Cancer Res201214120122277572
   PubMed Web of Science ®Google Scholar
• BuzdarAUAnastrozole (Arimidex™) – an aromatase inhibitor for the adjuvant setting?Br J Cancer200185Suppl 261011900212
   PubMedGoogle Scholar
• ShaviGVNayakUYMaliyakkalNNanomedicine of anastrozole for breast cancer: physicochemical evaluation, in vitro cytotoxicity on BT-549 and MCF-7 cell lines and preclinical study on rat modelLife Sci201514114315526423561
   PubMed Web of Science ®Google Scholar
• EdiriwickremaASaltzmanWMNanotherapy for cancer: targeting and multifunctionality in the future of cancer therapiesACS Biomater Sci Eng201512647825984571
   PubMed Web of Science ®Google Scholar
• DongXMumperRJNanomedicinal strategies to treat multidrug-resistant tumors: current progressNanomedicine (Lond)20105459761520528455
   PubMed Web of Science ®Google Scholar
• ZidanASSammourOAHammadMAMegrabNAHussainMDKhanMAHabibMJFormulation of anastrozole microparticles as biodegradable anticancer drug carriersAAPS PharmSciTech2006736117025242
   PubMed Web of Science ®Google Scholar
• SarkarKYangHEncapsulation and extended release of anti-cancer anastrozole by stealth nanoparticlesDrug Deliv200815534334618763165
   PubMed Web of Science ®Google Scholar
• KumarASawantKKApplication of multiple regression analysis in optimization of anastrozole-loaded PLGA nanoparticlesJ Microen-capsul2014312105114
   PubMed Web of Science ®Google Scholar
• ChengJTeplyBASherifiIFormulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug deliveryBiomaterials200728586987617055572
   PubMed Web of Science ®Google Scholar
• WhiteheadKALangerRAndersonDGKnocking down barriers: advances in siRNA deliveryNat Rev Drug Discov20098212913819180106
   PubMed Web of Science ®Google Scholar
• WangQBaoYAhireJChaoYCo-encapsulation of Biodegradable Nanoparticles with Silicon Quantum Dots and Quercetin for Monitored DeliveryAdv Healthc Mater20132345946623184534
   PubMed Web of Science ®Google Scholar
• MassadehSAlaameryMAl-QatananiSAlarifiSBawazeerSAlyafeeYSynthesis of protein-coated biocompatible methotrexate-loaded PLA-PEG-PLA nanoparticles for breast cancer treatmentNano Rev2016710.3402/nano.v7.31996
   Google Scholar
• DukesMEdwardsPNLargeMSmithIKBoyleTThe preclinical pharmacology of “Arimidex” (anastrozole; ZD1033) – a potent, selective aromatase inhibitorJ Steroid Biochem Mol Biol19965844394458903429
   PubMed Web of Science ®Google Scholar
• DanhierFFeronOPreatVTo exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug deliveryJ Control Release2010148213514620797419
   PubMed Web of Science ®Google Scholar
• ForouzanfarMHForemanKJDelossantosAMLozanoRLopezADMurrayCJNaghaviMBreast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysisLancet201137898011461148421924486
   PubMed Web of Science ®Google Scholar
• HarveyJMClarkGMOsborneCKAllredDCEstrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancerJ Clin Oncol19991751474148110334533
   PubMed Web of Science ®Google Scholar
• JiangQZhengSWangGDevelopment of new estrogen receptor-targeting therapeutic agents for tamoxifen-resistant breast cancerFuture Med Chem2013591023103523734685
   PubMed Web of Science ®Google Scholar
• XiaoRZZengZWZhouGLWangJJLiFZWangAMRecent advances in PEG–PLA block copolymer nanoparticlesInt J Nanomedicine201051057106521170353
   PubMed Web of Science ®Google Scholar
• FangJSawaTMaedaHFactors and mechanism of “EPR” effect and the enhanced antitumor effects of macromolecular drugs including SMANCSAdv Exp Med Biol2003519294912675206
   PubMed Web of Science ®Google Scholar
• KemalaTBudiantoESoegiyonoBPreparation and characterization of microspheres based on blend of poly(lactic acid) and poly(ε-caprolactone) with poly(vinyl alcohol) as emulsifierArabian Journal of Chemistry201251103108
   Web of Science ®Google Scholar
• ItohTKarlsbergKKijimaIYuanYCSmithDYeJChenSLetrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approachMol Cancer Res20053420321815831674
   PubMed Web of Science ®Google Scholar
• MurphyLOBlenisJMAPK signal specificity: the right place at the right timeTrends Biochem Sci200631526827516603362
   PubMed Web of Science ®Google Scholar
• BlagosklonnyMVSchulteTNguyenPTrepelJNeckersLMTaxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathwayCancer Res1996568185118548620503
   PubMed Web of Science ®Google Scholar
• PersonsDLYazlovitskayaEMPellingJCEffect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatinJ Biol Chem200027546357783578510958792
   PubMed Web of Science ®Google Scholar
• LiuJMaoWDingBLiangCERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytesAm J Physiol Heart Circ Physiol20082955H1956H196518775851
   PubMed Web of Science ®Google Scholar
• MeyerNPennLZReflecting on 25 years with MYCNat Rev Cancer200881297699019029958
   PubMed Web of Science ®Google Scholar
• ShiYGlynnJGuilbertLCotterTBissonnetteRGreenDRole for c-myc in activation-induced apoptotic cell death in T cell hybridomasScience199225750672122141378649
   PubMed Web of Science ®Google Scholar
• SearsRNuckollsFHauraETayaYTamaiKNevinsJRMultiple Ras-dependent phosphorylation pathways regulate Myc protein stabilityGenes Dev200014192501251411018017
   PubMed Web of Science ®Google Scholar
• Kauffmann-ZehARodriguez-VicianaPUlrichEGilbertCCofferPDownwardJEvanGSuppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKBNature199738566165445489020362
   PubMed Web of Science ®Google Scholar
• AllenTDZhuCQJonesKDYanagawaNTsaoMSBishopJMInteraction between MYC and MCL1 in the genesis and outcome of non-small cell lung cancerCancer Res20117162212222121406400
   PubMed Web of Science ®Google Scholar